Search Results
Search results for "Design Pharmaceuticals"
Results found for "Design Pharmaceuticals"
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Our refreshed schedule is designed to fit seamlessly into your calendar and enhance your learning experience (October 2-3, 2024, in Boston and online) gathers top researchers to explore the latest advances in designing
- Why Fundraising Mistakes Kill Strong Biotech Startups
👉 When that question becomes dominant, strategy quietly shifts from intentional design to reactive justification Founders delay narrowing focus, hoping clarity will emerge after the round instead of designing it upfront
- Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...
Group Corporation (“the Company”; TSE: 4565), the world leader in GPCR-focused structure-based drug design
- Roles of Focal Adhesion Kinase PTK2 and Integrin αIIbβ3 Signaling in Collagen- and GPVI-Dependent...
We designed and synthetized peptides that interfered with integrin αIIb binding (pCIB and pCIBm) or mimicked
- Functional molecular switches of mammalian G protein-coupled bitter-taste receptors
We designed an integrative approach to improve comparative modeling of TAS2Rs.
- Targeting Intracellular Allosteric Sites in GPCRs
The process of designing and evaluating biased ligands for GPCRs is complex but essential for understanding Advances in understanding the structural and mechanistic aspects of biased GPCR signaling are crucial for designing
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
to PK–PD dissociation, Kenakin equips you with the kinetic models and biological context needed to design
- How Fast Does a Drug Work?
Kenakin’s latest  lecture delivers exclusive, real-world insight designed to equip you to move beyond
- Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!
Logo Contest : Let your creativity shine by submitting your design for the Logo Contest before August
- Why GPCR Biologic Drugs Stabilize Active States Small Molecules Struggle to Reach
A Specific Difficulty, Not a General Verdict A pharmacologist designing an orthosteric small-molecule
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
The pharmacological profiles and mechanistic insights of our study provide clues for the future design
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
At Celtarys, our GPCR fluorescent ligands are designed with a variety of photophysical properties to
- Why “Displacement” Misleads You: Allosteric Binding Demystified
radioligand binding but suppresses functional response, it’s not broken pharmacology—it’s biology working as designed
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
MQ1-K39A represents the first step in the improvement of the MQ1 design from a medicinal perspective.
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
Red-flagging toxicophores accelerates rational design cycles Computational prediction complements biological
- How Schild Analysis Protects Your Conclusions in GPCR Research
GPCR University content, and an integrated view of publications, events, insights, and opportunities designed
- đź“° GPCR Weekly News, July 3 to 9, 2023
GPCR Binders, Drugs, and more Rational design of highly stabilized and selective adrenomedullin analogs
- GPCR Selectivity Beyond the Receptor — Live April 9th with Bryan Roth
Plus 6 industry updates and 1 new Masterclass recording now available — Purinergic GPCR Ligand Design
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
At Celtarys, we support this transition by offering optimized fluorescent ligands specifically designed
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
lectures, classified industry news, priority event alerts, job opportunities, and insider commentary—designed
- Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
receptor, which could participate in the recognition of MT1-selective ligands and may be exploited in the design
- In vivo metabolic effects after acute activation of skeletal muscle G s signaling
Methods: To address this question, we studied mice that express a Gs-coupled designer G protein-coupled
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
beyond natural agonist analogs Awareness of how GPCR allostery and biased signaling are redefining drug design
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
translational research models, further refining his interest in bridging molecular insights with therapeutic design
- How Collaboration Drives GPCR Discoveries
It will hinge on the teams who can map GPCR signaling with precision and design therapies that fit real
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
to 10th, 2024 Industry News Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments Five protein-design
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
Altogether, these aspects hint that the linker design and strategy can provide options for the tuning Structure-Based Design of High-Affinity Fluorescent Probes for the Neuropeptide Y Y1 Receptor. J. An Order of Magnitude Faster DNA-PAINT Imaging by Optimized Sequence Design and Buffer Conditions.
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
, Activation, and Signaling Pathways in the Brain An understanding of GPCR structure is key in drug design
- đź“° GPCR Weekly News, June 19 to 25, 2023
Methods & Updates in GPCR Research A coiled-coil-based design strategy for the thermostabilization of
- Quantifying Receptor Selectivity in Modern Drug Discovery
It is designed for: Pharmacologists sharpening foundational tools Discovery teams solving assay bottlenecks




















